Skip to Main Content
TRC_PLH
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs
  6. SSRIs

SSRIs

  • ADHD (37)
  • Agitation (2)
  • Anxiety (25)
  • Bipolar Disorder (8)
  • Depression (147)
    • Cardiovascular Disease and Depression (8)
    • Drugs (131)
      • Atypical Antipsychotics (45)
      • Benzodiazepines (36)
      • Bupropion (29)
      • MAOIs (9)
      • SNRIs (50)
      • SSRIs (74)
      • TCAs (30)
      • Typical Antipsychotics (1)
    • Natural Medicines/Supplements (9)
    • Pediatrics (9)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (4)
    • Seasonal Affective Disorder (1)
    • Treatment-Resistant Depression (14)
  • Mental Health (26)
  • Resources (131)
  • Schizophrenia (38)
  • Sleep Disorders (55)
  • Substance Use Disorder (166)
61 - 74 of 74 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Anticholinergics and the Elderly December 2011
Guideline: American Psychiatric Association Dementia Guideline (2011) October 2011
Commentary: Celexa (Citalopram) and QT Interval Prolongation October 2011
Guideline: Post-Traumatic Stress Disorder Management (2010) August 2011
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) July 2011
Commentary: New Drug: Viibryd (Vilazodone) July 2011
Commentary: Corticosteroid-Induced Psychiatric Effects May 2011
Guideline: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (2010) November 2010
Commentary: Depression Guidelines: Overview of Pharmacotherapy November 2010
Guideline: Health Care Protocol: Prevention of Falls (Acute Care) (2010) April 2010
Guideline: AGS/BGS Clinical Practice Guideline: Prevention of Falls in Older Persons (2010) April 2010
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) February 2010
Guideline: Depression and Coronary Disease: Screening, Referral, and Treatment February 2010
Commentary: Antidepressants and Cardiovascular Risk February 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved